Applied Therapeutics, Inc. Quarterly Debt-to-equity in % from Q3 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Applied Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q3 2019 to Q2 2024.
  • Applied Therapeutics, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 240 %, a 92.2% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 240 -2.85K -92.2% Jun 30, 2024
Q1 2024 748 +275 +58% Mar 31, 2024
Q4 2023 -575 -767 -399% Dec 31, 2023
Q3 2023 -1.12K -1.23K -1148% Sep 30, 2023
Q2 2023 3.09K +3.03K +4887% Jun 30, 2023
Q1 2023 474 +439 +1248% Mar 31, 2023
Q4 2022 192 +166 +629% Dec 31, 2022
Q3 2022 107 +83 +346% Sep 30, 2022
Q2 2022 62 +41.2 +198% Jun 30, 2022
Q1 2022 35.1 +16.1 +84.4% Mar 31, 2022
Q4 2021 26.4 +10.5 +65.9% Dec 31, 2021
Q3 2021 24 +7.85 +48.6% Sep 30, 2021
Q2 2021 20.8 +5.71 +37.8% Jun 30, 2021
Q1 2021 19.1 +3.96 +26.2% Mar 31, 2021
Q4 2020 15.9 -31 -66.1% Dec 31, 2020
Q3 2020 16.2 -87.3 -84.4% Sep 30, 2020
Q2 2020 15.1 Jun 30, 2020
Q1 2020 15.1 Mar 31, 2020
Q4 2019 46.9 Dec 31, 2019
Q3 2019 103 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.